Embla Medical hf. (CPH:EMBLA)
33.80
+0.70 (2.11%)
At close: Oct 24, 2025
Embla Medical Revenue
Embla Medical had revenue of $236.80M USD in the quarter ending September 30, 2025, with 10.90% growth. This brings the company's revenue in the last twelve months to $896.78M, up 6.72% year-over-year. In the year 2024, Embla Medical had annual revenue of $854.89M with 8.81% growth.
Revenue (ttm)
$896.78M
Revenue Growth
+6.72%
P/S Ratio
2.53
Revenue / Employee
$220.83K
Employees
4,061
Market Cap
14.45B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
| Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
| Dec 31, 2022 | 718.65M | -19.00K | - |
| Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
| Dec 31, 2020 | 629.50M | -56.76M | -8.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.87B |
| H. Lundbeck | 23.52B |
| Genmab | 23.16B |
| Demant | 22.59B |
| GN Store Nord | 17.33B |
| Zealand Pharma | 9.11B |
| Bavarian Nordic | 6.46B |
Embla Medical News
- 4 days ago - Embla Medical hf. (OSSUY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Embla Medical hf (OSSFF) Q3 2025 Earnings Call Highlights: Strong Prosthetics Growth Amidst ... - GuruFocus
- 4 days ago - Embla Medical Net Profit Climbs In Q3, Confirms FY25 Outlook; Stock Up - Nasdaq
- 5 days ago - Embla Medical hf: Interim Report Q3 2025 - PRNewsWire
- 2 months ago - Embla Medical hf: Embla Medical closes the majority share investment in Streifeneder ortho.production GmbH - PRNewsWire
- 3 months ago - Embla Medical hf: Interim Report Q2 2025 - PRNewsWire
- 3 months ago - Embla Medical hf: Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH - PRNewsWire
- 1 year ago - Embla Medical hf: Interim Report Q3 2024 - PRNewsWire